STL Volume 29 Number 1

Explore the groundbreaking role of Spesolimab, a novel interleukin-36 inhibitor, in treating Generalized Pustular Psoriasis flares in adults. This article presents key findings from phase 1 and 2 clinical trials, emphasizing Spesolimab's effectiveness and safety.

Explore the efficacy of 1726 nm lasers, specifically AviClear and Accure systems, in treating moderate to severe acne vulgaris, offering a safe and effective alternative to systemic therapies.

Update on Roflumilast foam, 0.3% (Zoryve®), Birch triterpenes gel (Filsuvez®), Rapamycin anhydrous gel, 3.9% (Qtorin™), Bimekizumab-bkzx for SC use (Bimzelx®), Secukinumab for SC use (Cosentyx®), and Ustekinumab-auub for SC/IV use (Wezlana™).